Frequent EpCam protein expression in human carcinomas.
暂无分享,去创建一个
Alessandro Lugli | Guido Sauter | G. Sauter | P. Went | S. Dirnhofer | M. Mirlacher | A. Lugli | Martina Mirlacher | Stephan Dirnhofer | S. Meier | M. Bundi | Philip Th Went | Sandra Meier | Marcel Bundi
[1] K. Huebner,et al. Retroposition in a family of carcinoma-associated antigen genes , 1993, Molecular and cellular biology.
[2] H. Moch,et al. Tissue microarray (TMA) technology: miniaturized pathology archives for high‐throughput in situ studies , 2001, The Journal of pathology.
[3] P. Went,et al. Edrecolomab in the adjuvant treatment of colorectal carcinoma , 2003, The Lancet.
[4] P. Möller,et al. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. , 1987, Cancer research.
[5] D. Sansonno,et al. Expression and distribution of a human colon-carcinoma-associated antigen in normal and diseased liver tissue. , 1993, Pathobiology : journal of immunopathology, molecular and cellular biology.
[6] M. Omary,et al. Multifocal heterogeneity in villin and Ep‐CAM expression in Barrett's esophagus , 1996, International journal of cancer.
[7] K. Klein,et al. Patterns of antigen distribution in human carcinomas. , 1990, Cancer research.
[8] J. V. van Krieken,et al. Expression of Ep‐CAM in normal, regenerating, metaplastic, and neoplastic liver , 1999, The Journal of pathology.
[9] S. Szala,et al. Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[10] D. Bostwick,et al. Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. , 1999, The Journal of urology.
[11] M. Borowitz,et al. Characterization of the human tumor and normal tissue reactivity of the KS1/4 monoclonal antibody. , 1988, Hybridoma.
[12] C. Cordon-Cardo,et al. Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[14] E. Schuuring,et al. Markers for assessment of nodal metastasis in laryngeal carcinoma. , 1997, Archives of otolaryngology--head & neck surgery.
[15] D. Edwards,et al. Cancer 43 , 000 Membrane Glycoprotein Associated with Human Breast r M Monoclonal Antibody Identification and Characterization of a Updated Version , 2006 .
[16] J. Packeisen,et al. Detection of surface antigen 17-1A in breast and colorectal cancer. , 1999, Hybridoma.
[17] P. Ruck,et al. Ep‐CAM in malignant liver tumours , 2000, The Journal of pathology.
[18] L. Schwartzberg. Clinical experience with edrecolomab: a monoclonal antibody therapy for colorectal carcinoma. , 2001, Critical reviews in oncology/hematology.
[19] A. Henry,et al. Molecular modeling and preclinical evaluation of the humanized NR-LU-13 antibody. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[20] P. Kufer,et al. In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment , 2002, International journal of cancer.
[21] C. Punt,et al. Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study , 2002, The Lancet.
[22] S. Litvinov,et al. The biology of the 17–1A antigen (Ep-CAM) , 1999, Journal of Molecular Medicine.
[23] R. Reisfeld,et al. Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies. , 1984, Cancer research.
[24] G. Riethmüller,et al. The epithelial cell surface antigen 17–1A, a target for antibody‐mediated tumor therapy: Its biochemical nature, tissue distribution and recognition by different monoclonal antibodies , 1986, International journal of cancer.
[25] O. Kallioniemi,et al. Tissue microarrays (TMAs) for high‐throughput molecular pathology research , 2001, International journal of cancer.
[26] P. Quirke,et al. Expression of the 17-1A antigen in gastric and gastro-oesophageal junction adenocarcinomas: a potential immunotherapeutic target? , 1999, Journal of clinical pathology.
[27] M. Herlyn,et al. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[28] G. Mikuz,et al. Prognostic significance of Ep‐CAM AND Her‐2/neu overexpression in invasive breast cancer , 2002, International journal of cancer.
[29] J. Izbicki,et al. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] K. Pienta,et al. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. , 2001, Human pathology.
[31] C. Cordon-Cardo,et al. Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group‐related antigens , 1997, International journal of cancer.
[32] J. Witte,et al. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] S. Braun,et al. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[34] Holger Moch,et al. Tissue Microarrays: What Will They Bring to Molecular and Anatomic Pathology? , 2001, Advances in anatomic pathology.
[35] E. Schuuring,et al. Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer , 2001, The Journal of pathology.
[36] D. Heimburger,et al. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung. , 2000, Human pathology.
[37] V. Reuter,et al. Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.